CNIO - Spanish National Cancer Research Centre
Miguel Quintela-Fandino is the Director Científico at TNC terapia since July 2023, focusing on the creation of precision therapeutic diets to aid cancer treatment. Since April 2010, Miguel has served as the Director of the Clinical Research Program at the Spanish National Cancer Research Centre (CNIO), a leading cancer research facility in Europe, facilitating the transition of basic research into clinical applications. Additionally, Miguel Quintela-Fandino has been an Assistant Professor at Universidad Autónoma de Madrid since October 2019, leading the Chair of Precision Oncology. Between March 2011 and October 2023, Miguel was the Head of the CNIO-Fuenlabrada Clinical Trials Unit, overseeing a team conducting oncology clinical trials. Educational qualifications include a Clinical Fellowship and Postdoctorate in Medical Biophysics from the University of Toronto, a Master's degree in Biostatistics from Universitat Autònoma de Barcelona, a PhD in Medicine from Universidad Complutense de Madrid, and an MD from the University of Navarra.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.